Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

Ex Input:
Paragraph: Health authorities across Asia have been stepping up surveillance and other precautions to prevent a repeat of the disruptions and deaths during the 2003 SARS crisis, which caused $40 billion to $50 billion in losses from reduced travel and spending. The first cases of what has been identified as a novel coronavirus were linked to a seafood market in Wuhan, suggesting animal-to-human transmission, but it now is also thought to be spread between people. As of Wednesday, more than 500 people were confirmed infected and 17 had died from the illness, which can cause pneumonia and other severe respiratory symptoms. A retreat in financial markets on Tuesday was followed by a rebound on Wednesday, as investors snapped up bargains. Share benchmarks were mostly higher both in Asia, Europe and the U.S. While the new virus appears much less dangerous than SARS, "the most significant Asia risk could lie ahead as the regional peak travel season takes hold, which could multiply the disease diffusion," said Stephen Innes, chief Asian strategist for AxiCorp. "So, while the risk is returning to the market, the lights might not turn green until we move through the Lunar New Year travel season to better gauge the coronavirus dispersion." The 2003 outbreak of Severe Acute Respiratory Syndrome in China, along with cases of a deadly form of bird flu, resulted in widespread quarantine measures in many Chinese cities and in Hong Kong. More than 8,000 people fell sick and just under 800 people died, a mortality rate of under 10%. While the ordinary flu kills hundreds of thousands of people each year, such new diseases raise alarm due to the uncertainties over how deadly they might be and how they might spread. That's especially true during the annual mass travel of the Lunar New Year festival, which begins this week. "The cost to the global economy can be quite staggering in negative GDP terms if this outbreak reaches epidemic proportions," Innes said in a report. In China, health officials stepped up screening for fevers. "We ask the public to avoid crowds and minimize the public gatherings to reduce the possibility of cross infection," Li Bin, deputy director of the National Health Commission, said Wednesday. As with SARS, the impact of the disease is likely to fall heaviest on specific industries, such as hotels and airlines, railways, casinos and other leisure businesses and retailers, analysts said. In a statement on its website Wednesday, Shanghai Disney Resort said it was operating normally but understood if some guests wished to change their travel plans. The park said it would let guests reschedule their visits or refund their money. China's Civil Aviation Administration called on airlines to offer free refunds for tickets in or out of Wuhan. "If the pneumonia couldn't be contained in the short term, we expect China's retail sales, tourism, hotel & catering, travel activities likely to be hit, especially in the first and second quarters," said Ning Zhang of UBS. Government efforts to offset the shock would help, but growth will likely rebound less than earlier forecast, Zhang said. The outbreak is a boon, meanwhile, for pharmaceutical companies and makers of protective masks and other medical gear. As of Jan. 17, the World Health Organization had not recommended any international restrictions on travel but urged local authorities to work with the travel industry to help prevent the disease from spreading while warning travelers who fall ill to seek medical attention. The illness is yet another blow for Hong Kong, whose economy is reeling from months of often violent anti-government protests. The wider concern is China, where the economy grew at a 30-year low 6.1% annual pace in 2019. An interim trade pact between Beijing and Washington had raised hopes that some pressure from tensions between the two biggest economies might ease, and the latest data have showed signs of improved demand for exports. The virus outbreak raises the risk such optimism might be premature. "We expect increased downward pressure on China's growth, particularly in the services sector," said Ting Lu and other analysts at Nomura in Hong Kong, who based their projections on the spread of the SARS virus. The growing number of global travelers has contributed to the spread of various diseases in recent years, including Middle East respiratory syndrome, the Ebola and Zika viruses, the plague, measles and other highly contagious illnesses. The World Economic Forum estimates that pandemics cross-border outbreaks like the flu that killed 50 million people a century ago have the potential to cause an $570 billion in annual economic losses. The 2014-16 Ebola virus epidemic caused losses amounting to over $2.2 billion, according to the World Bank. That includes a 40% decrease in the number of working Liberians at the height of the crisis, lower exports and harvests, and costs for combating the disease. Apart from the human tragedy, such crises gobble up resources needed for other government spending, exacting a harsh toll on the poorest economies. In Africa, the loss of health care workers to Ebola resulted in thousands more deaths of mothers and babies, hindered work on other diseases such as preventing and treating malaria, HIV/AIDS and tuberculosis, reduced vaccination rates and fewer surgeries, the World Bank said in a report. Many survivors, meanwhile, suffer from lingering effects of the illnesses and the powerful drugs used to save their lives, becoming more vulnerable to hunger and other risks. At the same time, increasingly sophisticated tools for collecting data and analyzing are aiding efforts to prepare for and cope with severe disease outbreaks. In 2016, the World Bank set up a $500 million rapid response insurance fund, working with the WHO and insurance companies, to combat pandemics in developing countries. The fund uses "cat bonds," or catastrophe bonds, whose principal will be lost if the funds are needed to help deal with an outbreak. Private insurers have followed with products of their own meant to hedge against risks from such disasters. Claim: China virus outbreak may wallop economy, financial markets.

Ex Output:
News that a new virus that has afflicted hundreds of people in central China can spread between humans has rattled financial markets and raised concern it might wallop the economy just as it might be regaining momentum.

Ex Input:
Paragraph: Serge Haroche of France and American David Wineland, both 68, found ways to manipulate the very smallest particles of matter and light to observe strange behavior that previously could only be imagined in equations and thought experiments. Wineland once described his own work as a "parlor trick" that performed the seemingly magical feat of putting an object in two places at once. Other scientists praised the achievements as bringing to life the wildest dreams of science fiction. "The Nobel laureates have opened the door to a new era of experimentation with quantum physics by demonstrating the direct observation of individual quantum particles without destroying them," said the Royal Swedish Academy of Sciences, which awarded them the 8 million crown ($1.2 million) prize. "Perhaps the quantum computer will change our everyday lives in this century in the same radical way as the classical computer did in the last century." Haroche said he was walking in the street with his wife when he recognized the Swedish country code on the incoming call to inform him of the award. "I saw the area code 46, then I sat down," he told reporters in Sweden by telephone. "First I called my children, then I called my closest colleagues, without whom I would never have won this prize," he said. Asked how he would celebrate, he said: "I will have champagne, of course." He told Reuters he hoped the prize would give him a platform "that will allow me to communicate ideas, not just in this field of research but for research in general, fundamental research". Wineland was asleep at home in Boulder, Colorado, when the phone call from Stockholm arrived before dawn on Tuesday morning, he said at a press conference. (His wife answered.) Physics is the second of this year's crop of awards; scientists from Britain and Japan shared the first prize on Monday, in medicine, for adult stem cell research. The prizes, which reward achievements in science, literature and peace, were first awarded in 1901 in accordance with the will of Swedish dynamite millionaire Alfred Nobel. "This year's Nobel Prize recognizes some of the most incredible experimental tests of the weirder aspects of quantum mechanics," said Jim Al-Khalili, professor of physics at the University of Surrey in Britain. "Until the last decade or two, some of these results were nothing more than ideas in science fiction or, at best, the wilder imaginations of quantum physicists. Wineland and Haroche and their teams have shown just how strange the quantum world really is and opened up the potential for new technologies undreamt of not so long ago." Quantum physics studies the behavior of the fundamental building blocks of the universe at a scale smaller than atoms, when tiny particles act in strange ways that can only be described with advanced mathematics. Researchers have long dreamt of building "quantum computers" that would operate using that mathematics - able to conduct far more complicated calculations and hold vastly more data than classical computers. But they could only be built if the behavior of individual particles could be observed. "Single particles are not easily isolated from their surrounding environment, and they lose their mysterious quantum properties as soon as they interact with the outside world," the Nobel committee explained. "Through their ingenious laboratory methods Haroche and Wineland, together with their research groups, have managed to measure and control very fragile quantum states, which were previously thought inaccessible for direct observation. The new methods allow them to examine, control and count the particles." Both scientists work in the field of quantum optics, studying the fundamental interactions between light and matter. The Nobel committee said they used opposite approaches to the same problem: Wineland uses light particles - or photons - to measure and control particles of matter - electrons - while Haroche uses electrons to control and measure photons. In one of the strange properties of quantum mechanics, tiny particles act as if they are simultaneously in two locations, based on the likelihood that they would be found at either, known as a "superposition." It was long thought that it would be impossible to demonstrate this in a lab. But Wineland's "parlor trick" was to hit an atom with laser light, which according to quantum theory had a 50 percent chance of moving it, and observe the atom at two different locations, 80 billionths of a meter apart. In a normal computer, a switch must either be on or off. A quantum computer would work with switches that, like the particles in Wineland's experiment, behaved as if they were in more than one position at the same time. An example is a computer trying to work out the shortest route around town for a travelling salesman. A traditional computer might try every possible route and then choose the shortest. A quantum computer could do the calculation in one step, as if the salesman travelled each route simultaneously. Wineland is a dedicated experimentalist, not bothered by the bizarre philosophical implications of quantum mechanics, such as the notion that reality does not exist until an observer measures it. "You can find debate on this, but I'm not sure we're so special in the universe" as to have the power to bring reality into being, he told Reuters. His realism extends to applications of his work. "I wouldn't recommend anybody buy stock in a quantum computing company," Wineland told reporters, but he said he was optimistic that it might be possible to build one eventually. He plans to be part of the quest. Asked if his science career was nearing an end, he said he had no plans to retire "until they drag me out of here for being too old". ($1 = 6.6125 Swedish crowns) Claim: "Nobel for quantum ""parlor trick"" that could make super computers."

Ex Output:
A French and an American scientist won the Nobel Prize in physics on Tuesday for finding ways to measure quantum particles without destroying them, which could make it possible to build a new kind of computer far more powerful than any seen before.

Ex Input:
Paragraph: The story does a good job of describing the monthly cost ($850) for women who do not have health insurance. The inference is that insurers will cover the cost for others. The story needed to include more information about the study resultsin particular, how both the drug and the placebo performed in the trials. As we learn from the NEJM study, the drug reduced pain for about half of the women who took itbut the placebo also reduced pain for about 35% of the women who took it. That's a good detail to include as it provides a better sense of the drug's effectiveness. The text does an impressive job of sharing information about the debits of the drug, including bone loss and symptoms of menopause. The double-blind, placebo-controlled trials are described, as are cautions, such as the short-term nature of the research. The reader will find ample information about the unpleasant symptoms of endometriosis. In some areas, it comes close to disease-mongering, when pointing out very rare instances of women needing many surgeries, or a case study of one woman having endometrial tissue in her nose. However, endometriosis is a medical condition, and often under-diagnosed, so we'll rate this satisfactory. The scientist who led the two trials is clearly identified as such, but his consulting relationship with the company now marketing the drug is not mentioned, nor is the fact that that company, now positioned to benefit from selling the drug, paid for the studies. A number of existing pain-reduction alternatives are mentioned, from hormonal treatments to surgery, and their debits discussed. It would have been helpful to try and articulate how many women find the current alternatives insufficient. The text offers a likely date when this just-approved drug would become available at pharmacies. Although the research report describing the trials was published in The New England Journal of Medicinemore than a year ago, this story is pegged to a more useful (to readers) "new event," the US Food and Drug Administration's approval of the drug. Abbvie, the company that funded the Stage 3 clinical trials of elagolix (brand name: Orilissa) and will now market the drug, made available an extensive news release on its web site. The Vox story contains a good bit of enterprise reporting and produced a story that is far more clear than the company's effort. Claim: Women with endometriosis experience terrible pain. There's finally a new treatment.

Ex Output:
The recent approval of a drug for the treatment of endometriosis pain is shared in this story in a way that satisfies many of our review site criteria. The story is carefully written, with lots of detailed explanations of the drug's potential benefits and drawbacks. Although some crucial information about funding and possible conflicts of interest is missing, the story otherwise affords the reader a readable and comprehensive "take" on the new drug. One clinical trial detail we think should have been included: The measured benefits for both the drug group and the placebo group. Endometriosis, a condition in which tissue migrates from the uterus into the abdomen of women, is relatively common and can be debilitatingly painful. While there is no cure at present, efforts to control the pain include hormonal treatments and even surgery, which produce their own complications. This story describes a new non-hormonal drug that appears to avoid somebut not allof those complications.